Stock Comparison

DNTH vs REGN

Dianthus Therapeutics Inc. and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

DNTH

Dianthus Therapeutics Inc.

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$5.84B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

—

17.1

Price/Sales

3,065.7

5.2

Price/Book

5.1

2.5

EV/EBITDA

-7.2

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-847.53%

29.65%

Operating Margin

-14318.04%

24.32%

Return on Equity

-26.10%

14.00%

Return on Assets

-17.70%

6.53%

Growth (YoY)

Revenue Growth

294.30%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

0.1

0.2

52-Week High

$112.64

$810.12

52-Week Low

$20.25

$553.38

Analyst Target

$137.62

$833.54

Compare DNTH and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.